Quarterly Results

RANBAXY LABORATORIES LTD.- (AMALGAMATION)

NSE : NABSE : 500359ISIN CODE : INE015A01028Industry : Pharmaceuticals & DrugsHouse : MNC
BSE859.900 (0 %)
PREV CLOSE ( ) 859.90
OPEN PRICE ( ) 814.90
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 859.90 (10542)
VOLUME 308222
TODAY'S LOW / HIGH ( )810.30 869.00
52 WK LOW / HIGH ( ) 810.3869
NSE
This Company is not listed in NSE
Quarters
Select year  
( in Million)
Particulars
Dec 2014
Sep 2014
Jun 2014
Mar 2014
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
26188.46
32604.91
24262.57
24668.21
Total Expenditure
25824.32
25180.97
22674.16
23623.08
PBIDT (Excl OI)
364.13
7423.94
1588.41
1045.13
Other Income
106.82
173.85
374.12
236.98
Operating Profit
470.96
7597.79
1962.53
1282.11
Interest
704.59
725.54
752.85
689.41
Exceptional Items
-152.82
-220.04
-2060.07
656.8
PBDT
-386.45
6652.21
-850.39
1249.5
Depreciation
967.68
1019.14
1074.23
953
Profit Before Tax
-1354.13
5633.07
-1924.62
296.5
Tax
8881.92
851.37
-55.86
1098.64
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
-10236.05
4781.7
-1868.76
-802.14
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
-10236.05
4781.7
-1868.76
-802.14
Minority Interest
-5.06
3.39
31.09
56.54
Shares of Associates
-56.16
-7.53
-21.61
9.06
Other related items
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
-10297.27
4777.56
-1859.28
-736.54
Equity Capital
2122.44
2119.49
2117.75
2116.6
Face Value (IN RS)
5
5
5
5
Reserves
NA
NA
NA
NA
Calculated EPS
-24.25
11.27
-4.38
-1.73
Calculated EPS (Annualised)
-97.03
45.08
-17.55
-6.95
No of Public Share Holdings
156289849
149313910
144852564
148773659
% of Public Share Holdings
36.77
35.22
34.18
35.11
 
NA
NA
NA
NA
PBIDTM% (Excl OI)
1.39
22.76
6.54
4.23
PBIDTM%
1.79
23.30
8.08
5.19
PBDTM%
-1.47
20.40
-3.50
5.06
PBTM%
-5.17
17.27
-7.93
1.20
PATM%
-39.08
14.66
-7.70
-3.25
 
Notes
Notes
Notes
Notes

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.